Medtronic
Medtronic is a global medical technology company that develops, manufactures, and sells devices and therapies for cardiac and vascular care, diabetes management, neurological and spinal conditions, and surgical procedures. It serves hospitals, physicians, and healthcare systems worldwide through a portfolio of implantable devices, surgical tools, and patient monitoring solutions. The company generates revenue primarily from the sale of medical devices, related consumables, and associated services and support contracts.
- Revenue
- $32.0B
- Employees
- 95,000
- Founded
- 1949
- Headquarters
- Minneapolis, United States of America
What 72 Arbolus experts think of Medtronic
NPS is skewed positive, with 41% of responses (15 of 37) as Promoters (score 9–10), 35% as Passives (15 of 37), and around 24% as Detractors (9 of 37). Renewal intent is reported as ‘Yes’ by all high spenders, while users in early or offboarding stages express lower intent or uncertainty. Stickiness improves significantly after the first year. Major positive themes include established device reliability and robust clinical support, while downsides center on workflow friction and alert management. Overall Customer Sentiment: Positive
Who reviewed Medtronic
- C-Suite 79% (57)
- Director 13% (9)
- Manager 8% (6)
Employer names and spend open in the full report, along with the other 69 customers.
Everything 72 customers told us about Medtronic.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
19 Net Promoter Score, from 72 scored reviews- Promoters 29
- Passives 28
- Detractors 15
Cumulative NPS by month
+0 over 6 months- Apr 8
- May 8
- Jun 8
- Jul 8
- Aug 8
- Sep 8
Net Promoter Score across 2 reviews, accumulated up to each month. Category median 18 across 2 companies.
Praised
- Seamless Interoperability
- AI-Driven Workflow Optimization
- Expansion of Customization and Automation
- Comprehensive Technical and Clinical Support
Criticised
- Regulatory and Compliance Shifts
- Competitive Advantage in AI Automation
- Loss of Patient Outcome Edge
- High Manual Review Burden
What customers say
Renewal intent
Plan to renew 53%Plan to renew, by seniority
- 42% 12 answers
- 100% 3 answers
- 50% 2 answers
- 9/10 Average score from customers who will renew
- 7.5/10 Average score from undecided customers
- 6/10 Average score from customers not renewing
Top alternatives
Most weighed by Medtronic customers
Report
For people who use Medtronic
Do you use Medtronic at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 72 customers of Medtronic have already contributed
Takes a few minutes. Your identity stays anonymous.